Item 2.02 Results of Operations and Financial Condition
On May 5, 2026, Pfizer Inc. (“Pfizer”) issued a press release announcing its financial results for the first quarter of 2026. A copy of the press release is furnished herewith as Exhibit 99 and is incorporated by reference herein.
The information furnished pursuant to this “Item 2.02 - Results of Operations and Financial Condition”, including Exhibit 99, shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing made by us under the Exchange Act or Securities Act of 1933, as amended, regardless of any general incorporation language in any such filing, except as shall be expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
Exhibit Number Exhibit Description
Exhibit 99 Press Release of Pfizer Inc. dated May 5, 2026, reporting Pfizer’s financial results for the first quarter of 2026.
104 Cover Page Interactive Data File--the cover page XBRL tags are embedded within the Inline XBRL document.
EXHIBIT INDEX
Exhibit No. Description
99 Press Release of Pfizer Inc. dated May 5, 2026, reporting Pfizer’s financial results for the first quarter of 2026.
104 Cover Page Interactive Data File--the cover page XBRL tags are embedded within the Inline XBRL document.